Dong-A Pharmaceutical Co.,Ltd. New non-registered executive reports holding of 220 common shares
Dong-A Pharmaceutical Co.,Ltd.· Insider Ownership
AI summary · Not investment advice
Newly appointed non-registered executive Lee Sang-won reported holding 220 common shares (0.00%) as of November 6, 2026.
Key facts
- Reporting person
- Lee Sang-won
- Relationship with issuer
- Non-registered executive, Senior Managing Director candidate (Sangmu-bo)
Commentary
AI commentary · Not investment advice
What happened
A newly appointed executive at Dong-A Pharmaceutical, Lee Sang-won, reported owning 220 common shares of the company.
In the company's terms
He is an unregistered executive (an officer not on the board) with the title of Sangmubo. He was newly appointed, so he had to report his holdings. His ownership ratio is 0.00%.
Earlier Insider Ownership filings from this company
| Filed | Title | Key figure · Note |
|---|---|---|
| 26.11.062026.11.06 | Insider Ownership | 67 shares · Common shares held following new appointment |
| 26.11.062026.11.06 | Insider Ownership | 30 shares |
| 26.11.062026.11.06 | Insider Ownership | 26 shares · New report, common shares |
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
D